Table 2.
Baseline characteristics of patients with attempted catheter insertions (n = 44)
| Characteristic | Value |
|---|---|
| Median age, yr (IQR) | 60 (55.0−64.0) |
| Male sex, n (%) | 35 (79.5) |
| Ethnicity, n (%) | |
| White | 8 (18.2) |
| Black | 26 (59.1) |
| Asian | 4 (9.1) |
| Other or mixed ethnic group | 6 (13.6) |
| Previous abdominal surgery | 3 (6.8) |
| Median body mass index (IQR) | 27.7 (23.3−31.8) |
| Comorbidities | |
| Diabetes, n (%) | 20 (45.5) |
| Hypertension, n (%) | 30 (68.2) |
| Cardiovascular disease, n (%) | 10 (22.7) |
| Median laboratory parameters at time of catheter insertion (IQR) | |
| Creatinine, μmol/l | 389 (220−475) |
| Urea, mmol/l | 24.6 (13.9−28.5) |
| Hemoglobin, g/dl | 79.0 (77.0−89.0) |
| Platelet count, ×109 /l | 270 (185−405) |
| APTTR | 1.3 (1.1−1.5) |
| INR | 1.1 (1.0−1.1) |
| Base excess | –1.4 (–4.9 to 0.4) |
| Median no. of days admission to ICU (IQR) | 13.5 (10.0−20.3) |
| Median SOFA score at time of catheter insertion | 16.0 (15.0−17.0) |
| Organ support prior to PD catheter insertion, n (%) | |
| Ventilation | 44 (100) |
| Median lowest PaO2:FiO2 ratio (n = 27) | 22.0 (17.0−29.5) |
| Vasopressorsa | 26 (61.9) |
| Median maximal dose of norepinephrinea, μg/kg per min | 0.14 (0.08−0.22) |
| CVVHDF | 39 (88.6) |
| Median no. of days of CVVHDF (IQR) | 9.0 (4.3−13.8) |
| Tracheostomy | 13 (29.5) |
APTTR, activated partial thromboplastin ratio; CVVHDF, continuous veno-venous hemodiafiltration; ICU, intensive care unit; INR, international normalized ratio; IQR, interquartile range; PD, peritoneal dialysis; SOFA, Sequential Organ Failure Assessment.
a
n = 42 (2 missing).